Effects of ovulation induction on ovarian morphology: An animal study

International Journal of Gynecological Cancer

Volumn 14, Issue 4, 2004, Pages 600-606

  Çelik, Çetin ^a   Gezginc K ^a   Aktan, M ^a   Acar, A ^a   Yaman, S T ^a   Gungor S ^a   Akyurek C ^a  

^a SELCUK UNIVERSITY   (Turkey)

Author keywords

Ovarian cancer; Ovulation induction

Indexed keywords

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER RISK; CARCINOGENESIS; CONTROLLED STUDY; EPITHELIUM DYSPLASIA; FEMALE; HISTOPATHOLOGY; NONHUMAN; OVARY CANCER; OVARY CYST; OVULATION INDUCTION; PRIORITY JOURNAL; RAT; RISK ASSESSMENT;

ANIMALS; CELL TRANSFORMATION, NEOPLASTIC; CHORIONIC GONADOTROPIN; FEMALE; FOLLICLE STIMULATING HORMONE, BETA SUBUNIT; OVARIAN NEOPLASMS; OVARY; OVULATION INDUCTION; PRECANCEROUS CONDITIONS; RATS;

EID: 4043167798     PISSN: 1048891X     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1048-891X.2004.14407.x     Document Type: Article

References (33)

1. Venn A, Watson L, Bruinsma F, Giles G, Healy D. Risk of cancer after use of fertility drugs with in vitro fertilisation. Lancet 1999;354:1586-90.
2. Shushan A, Paltiel O, Schenker GJ. Induction of ovulation and borderline ovarian cancer - the hormonal connection? Eur J Obstet Gynecol Reprod Biol 1999;85:71-4.
3. Shushan A, Laufer N. Fertility drugs and ovarian cancer: what are the practical implications of the ongoing debate? Fertil Steril 2000;74:8-9.
4. Bamford PN, Steele SJ. Uterine and ovarian carcinoma in a patient receiving gonadotropin therapy. Case report. Br J Obstet Gynaecol 1982;89:962-4.
5. Whittemore AS, Harris R, Itnyre J. Characteristics relating to ovarian cancer risk: collaborative analysis of 12 US case-control studies. II. Invasive epithelial ovarian cancers in white women. The Collaborative Ovarian Cancer Group. Am J Epidemiol 1992;136:1184-203.
6. Whittemore AS, Harris R, Itnyre J, Halpern J. Characteristics relating to ovarian cancer risk: collaborative analysis of 12 US case-control studies. I. Methods. The Collaborative Ovarian Cancer Group. Am J Epidemiol 1992;136:1175-83.
7. Harris R, Whittemore AS, Itnyre J. Characteristics relating to ovarian cancer risk: collaborative analysis of 12 US case-control studies. III. Epithelial tumors of low malignant potential in white women. The Collaborative Ovarian Cancer Group. Am J Epidemiol 1992;136:1204-11.
8. Ron E, Lunenfeld B, Menezer J et al. Cancer incidence in a cohort of infertile women. Am J Epidemiol 1987;125:780-90.
9. Kaufman SC, Spirtas R, Alexander NJ. Do fertility drugs cause ovarian tumors? J Women's Health 1995;4:247-59.
10. Dor J, Lerner-Geva L, Rapinovici J et al. Cancer incidence in a cohort of infertile women who underwent in vitro fertilization. Fertil Steril 2002;77:324-7.
11. Mosgaard BJ, Lidegaard Q, Kjaer SK, Schou G, Andersen AN. Infertility, fertility drugs, and invasive ovarian cancer: a case-control study. Fertil Steril 1997;67:1005-12.
12. Bristow RE, Karlan BY. Ovulation induction, infertility, and ovarian cancer risk. Fertil Steril 1996;66:499-507.
13. Hafez ESE. Reproduction and Breeding Techniques for Laboratory Animals. Philadelphia: Lea Febiger, 1970.
14. Grimbizis G, Tarlatzis BC, Bontis J et al. Two cases of ovarian tumors in women who had undergone multiple ovarian stimulation attempts. Hum Reprod 1995;10:520-3.
15. Shu XO, Brinton LA, Gao YT, Yuan JM. Population based case control study of ovarian cancer in Shanghai. Cancer Res 1989;49:3670-4.
16. Salle B, de Saint HP, Devouassoux M, Gaucherand P, Rudigoz C. Another two cases of ovarian tumours in women who had undergone multiple ovulation induction cycles. Hum Reprod 1997;12:1732-5.
17. Brinton LA, Hoover RN. Epidemiology of gynecologic cancers. In: Hoskins WJ, Perez CA, Young RC, eds. Principle and Practice of Gynecology Oncology. Philadelphia: JB Lippincott Co., 1992:9-12.
18. Hankinson SE, Golditz GA, Hunter DJ, Spencer TL, Rosner B, Stampfer MJ. A quantitative assessment of oral contraceptive use and risk of ovarian cancer. Obstet Gynecol 1992;80:708-14.
19. Fathalla MF. Incessant ovulation a factor in ovarian neoplasia. Lancet 1971;2:163.
20. Zajicek J. Prevention of ovarian cystomas by inhibition of ovulation: a new concept. J Reprod Med 1978;2:114.
21. Stadel BV. The etiology and prevention of ovarian cancer. Am J Obstet Gynecol 1975;123:772-4.
22. Daly MB. The epidemiology of ovarian cancer. Hematol Oncol Clin North Am 1992;6:729-38.
23. Cramer DW, Welch WR. Determinants of ovarian cancer risk II: inferences regarding pathogenesis. J Natl Cancer Inst 1983;71:717-21.
24. Bandera CA, Cramer DA, Friedman AJ, Sheets EE. Fertility therapy in the setting of a history of invasive epithelial ovarian cancer. Gynecol Oncol 1995;58:116-8.
25. Rossing MA, Daling JR, Weiss NS, Moore DE, Self SG. Ovarian tumors in a cohort of infertile women. N Engl J Med 1994;331:771-6.
26. Nieto JJ, Crow J, Sundaresan M et al. Ovarian epithelial dysplasia in relation to ovulation induction and nulliparity. Gynecol Oncol 2001;82:344-9.
27. Harlow BL, Weiss NS, Roth GJ, Chu J, Daling JR. Case-control study of borderline tumors: reproductive history and exposure to exogenous female hormones. Cancer Res 1988;48:5849-52.
28. Trimble CL, Trimble EL. Management of epithelial ovarian tumors of low malignantant potential. Gynecol Oncol 1994;55:S52-61.
29. Mittal OKR, Jacquotte AZ, Cooper JL, Demopoulos RI. Contralateral ovary in unilateral ovarian carcinoma: a search for preneoplastic lesions. Int J Gynecol Pathol 1993;12:59-63.
30. Gusberg MSB, Deligdisch L. Ovarian dysplasia. A study of identical twins. Cancer 1984;54:1-4.
31. Plaxe LSC, Deligdýsch L, Dottino PR, Cohen CJ. Ovarian intraepithelial neoplasia demonstrated in patients with stage I overian carcinoma. Gynecol Oncol 1990;38:367-72.
32. Resta LN, Russo S, Coluccý GA, Prat J. Morphologic precursors of ovarian epithelial tumors. Obstet Gynecol 1993;82:181-6.
33. Venn A, Jones P, Quinn M, Healy D. Characteristics of ovarian and uterine cancers in a cohort of in vitro fertilization patients. Gynecol Oncol 2001;82:64-8.